Antimicrobial resistance (AMR) is a recognised global public health threat and silent pandemic. The misuse and overuse of antibiotics in humans, animals and crops is leading to antibiotics becoming ineffective. But this is not all. While we are not conserving the existing stock of medicines, at the other end of spectrum, the pipeline for new antibiotics is drying up because of increasingly lesser research on new antibiotics. This means in the years to come, we are going to face a dire health emergency
Our recent assessment has shown that major pharmaceutical companies are opting out of research and development for new antibiotics not just because it is a high-risk and low-return proposition, but also because there is much more profit in drugs that are used for treating diseases like cancer or diabetes. Small and medium antibiotic developers are also facing big challenges. It is also clear that the current support provided is not enough and a lot needs to be done to stimulate the antibiotic R&D ecosystem for a sustainable and equitable antibiotic access. It is time to think about antibiotics as a ‘global public good’.
Centre for Science and Environment (CSE) invites you attend the first of its three-part webinar series – The Antibiotic Webinars: The crisis in antibiotic research and development. This would be followed by webinars on recognising antibiotics as a ‘global public good’ and on working towards resolving this crisis.
Please note: This is a free Zoom webinar, and registration is open to all. All those who register will receive an automatic confirmation. However, the webinar can accommodate a limited number of attendees on a first come-first served basis only. Therefore, please try to join 5 minutes before the scheduled time.
FOR MORE DETAILS, CONTACT:
+91 88168 18864
|Very few new antibiotics being developed, even as antibiotic resistance grows – this is signalling a dire public health emergency that needs global coordinated action: CSE|
|DTE: Cover Story|
|A Developing Crisis
July 16-31, 2023
|Coordination, collaboration key to solving crisis of antibiotic development|
|Pushing antibiotic development agenda needs more support|
|The Crisis in Antibiotic Research and Development
By: Rajeshwari Sinha
Sustainable Food Systems programme, CSE
Director General, CSE and Member, Global Leaders Group on AMR
Global Health, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Switzerland
Senior Project Manager
Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARBX), USA
Director of the Secretariat
Global AMR R&D Hub, Germany
Sustainable Food Systems programme CSE, New Delhi
Sustainable Food Systems Programme
Sustainable Food Systems Programme, CSE